Skip to main content

Bristol Myers to Buy Karuna Therapeutics for $14B

By The Wall Street Journal  
   December 22, 2023

The cash deal would help Bristol establish a beachhead in neuroscience drugs, including a schizophrenia treatment up for approval.

Full story


Get the latest on healthcare leadership in your inbox.